Navigation Links
Covance Reports Second Quarter Net Revenue of $592 Million, Pro Forma EPS of $0.78 and Record Adjusted Net Orders of $776 Million
Date:7/30/2013

ngs(81)(81)Net (loss) income $
(12,677)$
,530$
39,723$
2,746$
-$
36,322Basic (loss) earnings per share$
(0.23)$
.12$
.73$
.05$
.67Weighted average shares outstanding - basic54,184,96654,184,96654,184,96654,184,96654,184,966Diluted (loss) earnings per share$
(0.23)$
.12$
.73$
.05$
(0.02)$
.65Weighted average shares outstanding - diluted54,184,96654,184,96654,184,96654,184,9661,500,115(4)55,685,081(1) Represents costs incurred to better align capacity to preclinical market demand and reducecost structure.(2) Consists of inventory impairment ($20,781), goodwill impairment ($17,959) and impairment ofequity investment ($7,373).(3) Represents results of operations at sites where wind-down activities have commenced.(4) Reflects inclusion of impact of common stock equivalents in computation of diluted earningsper share as GAAP loss transitions to Pro Forma income. COVANCE INC.GAAP to Pro Forma ReconciliationYTD Q2 2013(Dollars in thousands, except per share data)(UNAUDITED)AdjustmentsGAAP Restructuringand Other Cost Reduction Activities (1)Other
Items (2)Pro FormaNet revenues$ 1,172,497$ 1,172,497Reimbursable out-of-pocket expenses105,814105,814Total revenues1,278,311--1,278,311Costs and expenses:  Cost of revenue830,459830,459  Reimbursable out-of-pocket expenses105,814105,814  Selling, general and administrative179,396(10,101)169,295  Depreciation and amortization62,881(2,082)60,799Total costs and expenses1,178,550(12,183)-1,166,367Income from operations99,76112,183-111,944Other (income) expense, net:  Interest expense, net1,8751,875  Foreign exchange transaction loss, net1,0291,029  Gain on sale of investments(16,400)16,400-Other (income) expense, net(13,496)-16,4002,904Income before taxes113,25712,183(16,400)109,040Taxes on income24,0973,894(5,746)22,245Net income $
89,160$
8,289$
(10,654)$
86,795Basic earnings per share$'/>"/>
SOURCE Covance Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Covance Central Laboratory Services Again Ranks #1 in Global Investigator Satisfaction Survey
2. Covance To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
3. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
4. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
5. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2013 Financial Results Conference Call
6. Covance To Present At The Citi 2013 Global Healthcare Conference
7. Covance To Present At The Leerink Swann Global Healthcare Conference
8. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
9. Covance To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
10. Covance Reports Third Quarter Pro Forma Net Revenue Of $542 Million, Pro Forma EPS Of $0.72 And Adjusted Net Orders Of $701 Million
11. Covance to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 The Leukemia & Lymphoma Society ... advance an experimental cancer vaccine to treat patients ... of myeloma. The partnership is through ... forges collaborations with biotechnology companies to help bring ... is developing a vaccine, PVX-410, designed to target ...
(Date:8/28/2014)... -- STAAR Surgical Company (NASDAQ: STAA ) a leading ... for the eye, today announced that management will present at ... Palace Hotel on Wednesday, September 3 at 7:15 a.m. PT/10:15 ... CEO will offer a general overview of the Company,s current ... by Steve Brown , CFO, and Sam Gesten ...
(Date:8/27/2014)... SHENZHEN, China, Aug. 28, 2014 China ... ("Nepstar" or the "Company"), a leading retail drugstore ... directly operated stores, today announced its unaudited financial ... Financial HighlightsFor the quarter ended June 30, ... RMB686.6 million (US$110.7 million) compared to RMB638.8 million in ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11
... TAINAN, Taiwan, Nov. 19 ... pharmaceutical ingredients (APIs), announced that its,Tainan facility has ... Inc. The Certification confirms ScinoPharm,s,competency and proficiency in ... and applies to specific laboratories and,production areas used ...
... , , DAYTON, Ohio, Nov. 19 Riverain ... with leading Canadian medical imaging distributor Christie Group to ... CAD. The exclusive agreement will bring Dayton, Ohio based ... Group,s established and reputable sales channel. , SoftView Enhanced ...
Cached Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2
(Date:8/28/2014)... Clarity PSO , an operating ... a federal Patient Safety Organization (PSO) for another three-year ... Research and Quality (AHRQ). Clarity PSO will continue to ... following the true intentions of the Patient Safety and ... proud and eager to continue our journey as a ...
(Date:8/28/2014)... Salt Lake City, UT (PRWEB) August 28, 2014 ... more attention to coordination and integration of care to address ... to improve the quality of care outcomes (with more provider ... are anticipated where all the people involved in the care ... and have to figure out how to distribute it. If ...
(Date:8/28/2014)... On September 10, the Mesothelioma Applied Research ... president and CEO of Aduro BioTech, during a new ... live broadcast. The interview will be led by ... nurse practitioner, Mary Hesdorffer, APRN . , The ... therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 ...
(Date:8/28/2014)... 28, 2014 Hastings and Hastings, a ... of experience in the industry is pleased to report ... that totaled approximately $125,000. This is exciting news for ... clear and well defined proof that Hastings and Hastings ... discount attorney's fees. Saving clients money when it comes ...
(Date:8/28/2014)... Vitals, a recognized and trusted website for finding and ... Dermatology one of their Top 10 Doctors for 2014 ... their doctor experiences and rate their doctors on a number ... Vitals Top 10 Doctor recognition means that out of all ... the highest by patients. , “I’m honored to receive this ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Med-Certification.com Expects Industry "Hiccups" with New Models for Patient Care and Reimbursement 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2
... heart risk may not be accurate in some cases ... from the United States and the Netherlands, question the ... in predicting heart disease and cardiovascular death. , The ... in that Massachusetts community, allows doctors to assess risk ...
... Alliance of relief organizations offers five action steps to ... cease fires to allow the delivery of food and ... of 750,000 people still lack access to food, clean ... working in the region see this arrangement to allow ...
... Senator Dole introduces Senator Daschle at his confirmation hearing ... Services , WASHINGTON, Jan. 8 Bipartisan Policy Center ... Department of Health and Human Services Secretary, was introduced ... at his confirmation hearing today. The hearing was convened ...
... bad cholesterol more effectively than Zocor , , THURSDAY, Jan. ... review, U.S. health officials said Thursday that they supported ... , The U.S. Food and Drug Administration said there ... patients taking Vytorin and patients taking the drug Zocor. ...
... Healthcare,Solutions, Inc., formerly Allscripts Healthcare Solutions, Inc. (Allscripts ... the three and six,months ended November 30, 2008. ... ) , The Company,s ... November 30, 2008,include results from legacy Allscripts for ...
... Jan. 8 The Pew Charitable Trusts announced today ... and food safety programs, in its Health & Human ... director and general counsel of the Senate Committee on ... experience in environmental policy and consumer advocacy to Pew. ...
Cached Medicine News:Health News:Studies Challenge Framingham Risk Score 2Health News:Studies Challenge Framingham Risk Score 3Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 2Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 3Health News:Bipartisan Policy Center Founding Board Members Daschle and Dole Appear on Capitol Hill 4Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2
For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
... Inquiry H Steerable Catheter. Steerable ... variety of designs and a ... stability. 10 to 24 electrodes, ... inactive and active tip electrodes, ...
Sophisticated DecaPolar Catheters provide enhanced recording and mapping quality....
... Torqr Quadripolar Braided Shaft ... The Medtronic CardioRhythm Torqr ... use in diagnostic electrophysiologic ... designed for recording intracardiac ...
Medicine Products: